Brett Hall

Brett Hall

Directeur Technique/Scientifique/R&D chez IMMUNEERING CORPORATION

Fortune : 2 M $ au 31/08/2026

57 ans
Health Technology
Consumer Services
Electronic Technology

Profil

Brett Hall was the founder of Bioarkive, Inc., founded in 2019, serving as Chairman & President from 2019 to 2021.
Dr. Hall is also the founder of Trans Medical Sciences LLC..
Dr. Hall is Chief Scientific Officer at Immuneering Corp.
since 2019.
Dr. Hall was Chief Executive Officer at Asellus Therapeutics LLC from 2015 to 2018.
Dr. Hall was Head-Translational Medicine at MedImmune LLC from 2014 to 2015.
Dr. Hall was Assistant Professor at The Ohio State University from 2004 to 2008.
Dr. Hall completed undergraduate education at The Ohio State University.
Dr. Hall earned a doctorate from West Virginia University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/06/2026 382 531 ( 0,59% ) 2 M $ 31/08/2026

Postes actifs de Brett Hall

SociétésPosteDébut
IMMUNEERING CORPORATION Directeur Technique/Scientifique/R&D 01/11/2019

Anciens postes connus de Brett Hall

SociétésPosteFin
Fondateur 01/12/2021
Directeur Général 01/05/2018
Corporate Officer/Principal 01/07/2015
Corporate Officer/Principal 01/10/2008
Voir l'expérience en détail de Brett Hall

Formation de Brett Hall

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

76

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Electronic Technology

  1. Bourse
  2. Insiders
  3. Brett Hall
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT